Ajanta Pharma Ltd.
Industry
- Pharmaceuticals
- Generic Drugs
See more in Biomedtracker
Latest on Ajanta Pharma Ltd.
Scrip
• By Vibha Ravi
India’s pharmaceutical companies are likely to see FY24 year-on-year growth in US market revenues slow down to 6-8% from 16% seen in FY23, based on its coverage universe of 25 companies, rating agency
Generics Bulletin
• By Chloe Kent
Indian specialty pharmaceutical company Ajanta Pharma Ltd. ’s Q3 results saw revenue up by 12% year on year, netting INR8.38bn ($112m) compared to INR7.49bn the previous year. While the company saw i